This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Miltenyi Biotec
product type :
antibody
product name :
CD87 Antibody, anti-human, FITC
catalog :
130-099-468
quantity :
100 tests in 1 mL
price :
264 USD
clonality :
monoclonal
host :
mouse
conjugate :
FITC
clone name :
VIM5
The same clone is also sold as:
The same clone is also sold as:
- Bio-Rad: MCA2516EL, MCA2516A647T, MCA2516A647, MCA2516F, MCA2516A488T, MCA2516A488, MCA2516GA
- BioLegend: 336902, 336905, 336906
- Invitrogen: MA5-28588, 46-3879-42, 17-3879-42
- BD Biosciences: 555767, 555768
- Exbio: 1P-792-T025, 11-792-C100, 1P-792-T100, 11-792-C025
reactivity :
human
application :
flow cytometry
citations: 2
Reference |
---|
Ge Y, Elghetany M. Urokinase plasminogen activator receptor (CD87): something old, something new. Lab Hematol. 2003;9:67-71 pubmed
|
Tarui T, Mazar A, Cines D, Takada Y. Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction. J Biol Chem. 2001;276:3983-90 pubmed
|
product information
MB Cataloge Number :
130-099-468
Catalog Number :
130-099-468
Product Name :
CD87 Antibody, anti-human, FITC
Product Type :
Primary antibodies
Host Species :
mouse IgG1κ
Clonality :
monoclonal
Conjugation :
FITC
Antigen Modification :
CD87
Clone Name :
VIM5
Isotype :
Isotype Control Antibody, mouse IgG1
Size :
100 tests in 1 mL
US List Price :
264 USD
Product Description :
Identification and enumeration of CD87+ cells by flow cytometry
CrossReactivity :
chimpanzee (Pan troglodytes)
ALTnames :
PLAUR, U-PAR, URKR
Specificity :
human, non-human primate
Concentration :
1:11
Uses :
For research use only
Application Summary :
Flow cytometry
Storage :
Store protected from light at 2–8 °C. Do not freeze.
company information
Miltenyi Biotec
Friedrich-Ebert-Strae 68
51429 Bergisch Gladbach
51429 Bergisch Gladbach
macs@miltenyibiotec.com
https://www.miltenyibiotec.com1 800 FOR MACS
headquarters: Germany
questions and comments